D. Vaira

发表

Review article:invasive and non-invasive tests for Helicobacter pylori infection.

J. Holton, M. Miglioli, L. Gatta, 2000, Alimentary pharmacology & therapeutics.

Evolution of Drug Interactions With Antiretroviral Medication in People With HIV

M. Moutschen, D. Vaira, G. Darcis, 2020, Open forum infectious diseases.

Infection by CagA-Positive Helicobacter pylori Strains in Patients with Ischemic Heart Disease: Prevalence and Association with Exercise-Induced Electrocardiographic Abnormalities

A. Palazzuoli, C. Gennari, L. Gennari, 2002, Digestive Diseases and Sciences.

Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication deficits.

Guangdi Li, A. Vandamme, F. Rousseau, 2014, Virology.

Chronic and early antiretroviral therapy impact HIV serological assay sensitivity leading to more false negative test results in HIV diagnosis.

K. Van Laethem, C. Verhofstede, K. Fransen, 2020, The Journal of infectious diseases.

High frequency of new recombinant forms in HIV-1 transmission networks demonstrated by full genome sequencing.

L. Hebberecht, C. Verhofstede, D. Vaira, 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Exploring HIV-1 Transmission Dynamics by Combining Phylogenetic Analysis and Infection Timing

K. Van Laethem, C. Verhofstede, K. Fransen, 2019, Viruses.

Phylogenetic analysis of the Belgian HIV-1 epidemic reveals that local transmission is almost exclusively driven by men having sex with men despite presence of large African migrant communities.

M. Van Ranst, K. Van Laethem, C. Verhofstede, 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Detectability of HIV Residual Viremia despite Therapy Is Highly Associated with Treatment with a Protease Inhibitor-Based Combination Antiretroviral Therapy

M. Moutschen, D. Vaira, G. Darcis, 2019, Antimicrobial Agents and Chemotherapy.

Comparison of 3 Tests for Plasma HIV-1 RNA Quantitation of Non-B Subtypes in Patients Infected with HIV-1 in N’Djamena-Chad: Cobas AmpliPrep/Cobas TaqMan HIV-1 Test Version 2.0, Abbott m2000 RealTime and Generic HIV Viral Load® Assays

M. Moutschen, A. Moussa, C. Adawaye, 2018 .

Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa

D. Vaira, R. Boreux, E. Kamangu, 2014 .

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment

L. Stuyver, I. Vandenbroucke, M. Moutschen, 2010, The Journal of antimicrobial chemotherapy.

Concordance between HIV‐1 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA

L. Vandekerckhove, S. De Wit, A. Geretti, 2011, HIV medicine.

Helicobacter pylori infection: anything new should we know?

J. Holton, G. Liuzzi, L. Gatta, 2004, Alimentary pharmacology & therapeutics.

Prevalence and Evolution of Transmitted Human Immunodeficiency Virus Drug Resistance in Belgium Between 2013 and 2019

K. Van Laethem, C. Verhofstede, D. Vaira, 2022, Open forum infectious diseases.

Accurate diagnosis of Helicobacter pylori. Stool tests.

S. Berardi, M. Miglioli, L. Gatta, 2000, Gastroenterology clinics of North America.

Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects

M. Rugge, N. Vakil, J. Holton, 2003, Gut.

Distribution of HCV genotypes in Belgium from 2008 to 2015

V. Hutse, R. Cartuyvels, K. Lagrou, 2018, PloS one.

Postnatal transmission of human immunodeficiency virus type 1 from mother to infant.

E. Karita, F. Dabis, P. Van de Perre, 1991, Disease markers.

Helicobacter pylori infection and infertility

P. Piomboni, C. Gennari, L. Gennari, 2002, European journal of gastroenterology & hepatology.

Routes of transmission of Helicobacter pylori infection.

J. Holton, M. Miglioli, L. Gatta, 1998, Italian journal of gastroenterology and hepatology.

Hepatitis C Virus Genotype 5 in Southern Belgium: Epidemiological Characteristics and Response to Therapy

J. Belaiche, D. Vaira, B. Bastens, 2005, Digestive Diseases and Sciences.

Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: Analysis of the HIV-2 Belgium and Luxembourg database

K. Van Laethem, C. Verhofstede, J. Schmit, 2008, BMC infectious diseases.

Mouse mammary tumor virus (MMTV) infection in SWISS and RIII mice

P. Hainaut, C. Calberg‐Bacq, D. Vaira, 2005, Archives of Virology.

Growth and Adult Height in Atypical Coeliac Patients, With or Without Growth Hormone Deficiency

D. Elleri, U. Volta, D. Vaira, 2005, Journal of pediatric endocrinology & metabolism : JPEM.

First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting

K. Kabeya, N. Clumeck, D. Vaira, 2014, AIDS.

Use of Dried Blood Spot to Improve the Diagnosis and Management of HIV in Resource-Limited Settings

M. Moutschen, A. Moussa, C. Adawaye, 2013 .

An Improved Protocol for Efficient Engraftment in NOD/LTSZ-SCIDIL-2RγNULL Mice Allows HIV Replication and Development of Anti-HIV Immune Responses

L. de Leval, G. Vanham, S. Rahmouni, 2012, PloS one.

Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda.

E. Karita, P. Msellati, A. Stevens, 1991, The New England journal of medicine.

Cancer of the gastric stump in Italy, 1979-1986.

R. Muratori, L. Gandolfi, D. Vaira, 1988, Gastrointestinal endoscopy.

Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis.

R. Negrini, B. Appelmelk, F. Buffoli, 1996, Gastroenterology.

Epidemiological profiles of human immunodeficiency virus and hepatitis C virus infections in Malian women: Risk factors and relevance of disparities.

L. Seidel, D. Vaira, S. Bontems, 2013, World journal of hepatology.

Observer variation in histological assessment of Helicobacter pylori on gastric biopsies.

S. Pileri, A. Amorosi, R. Santucci, 1996, The American journal of gastroenterology.

Activation of human immunodeficiency virus type 1 by oxidative stress.

J. Pincemail, J. Piette, S. Legrand-Poels, 1990, AIDS research and human retroviruses.

Detection of Aspergillus Species DNA by PCR in Bronchoalveolar Lavage Fluid

P. de Mol, P. Melin, M. Hayette, 2001, Journal of Clinical Microbiology.

Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017

M. Moutschen, D. Vaira, G. Darcis, 2018, Scientific Reports.

Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. The Belgian AIDS Reference Laboratories.

A. Vandamme, C. Verhofstede, K. Fransen, 1995, Journal of virological methods.

Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection

K. Van Laethem, L. Hebberecht, C. Verhofstede, 2017, BMC Infectious Diseases.

Most Helicobacter pylori-Infected Patients Have Specific Antibodies, and Some Also Have H. pylori Antigens and Genomic Material in Bile: Is It a Risk Factor for Gallstone Formation?

C. Vindigni, C. Gennari, D. Vaira, 1998, Digestive Diseases and Sciences.

cagA positive and negative Helicobacter pyloristrains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage

C. Vindigni, D. Marrelli, A. Covacci, 1998, Gut.

Late presentation to HIV testing is overestimated when based on the consensus definition

M. Van Ranst, A. Pharris, M. Moutschen, 2015, HIV medicine.

Family treatment of symptomatic children with Helicobacter pylori infection.

A. Ponzetto, D. Vaira, N. Ansaldi, 1997, Italian journal of gastroenterology and hepatology.

Blinded, multicenter quality control study for the quantification of human immunodeficiency virus type 1 RNA in plasma by the Belgian AIDS reference laboratories.

A. Vandamme, G. Zissis, A. Vandamme, 2000, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of switch from tenofovir disoproxil fumarate-based regimens to tenofovir alafenamide-based regimens on lipid profile, weight gain and cardiovascular risk score in people living with HIV

M. Moutschen, N. Paquot, D. Vaira, 2021, BMC Infectious Diseases.

Minocycline attenuates HIV‐1 infection and suppresses chronic immune activation in humanized NOD/LtsZ‐scidIL‐2Rγnull mice

S. Rahmouni, M. Moutschen, Maneesh Singh, 2014, Immunology.

Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care

K. Van Laethem, P. Messiaen, M. Moutschen, 2022, BMC Infectious Diseases.

Factors associated with the continuum of care of HIV-infected patients in Belgium

M. Van Ranst, M. Moutschen, P. Lacor, 2014, Journal of the International AIDS Society.

Prevalence of HIV and HCV infections in two populations of Malian women and serological assays performances.

L. Seidel, D. Vaira, S. Bontems, 2012, World journal of hepatology.

Downregulation of CD94/NKG2A inhibitory receptors on CD8+ T cells in HIV infection is more pronounced in subjects with detected viral load than in their aviraemic counterparts

S. Rahmouni, M. Moutschen, N. Schaaf-Lafontaine, 2007, Retrovirology.

Evolution over a 10 year period of the epidemiological profile of 1,726 newly diagnosed HCV patients in Belgium

D. Vaira, B. Bastens, J. Delwaide, 2005, Journal of medical virology.

Helicobacter pylori infection from pathogenesis to treatment – a critical reappraisal

J Holton, F. Perna, J. Holton, 2002, Alimentary pharmacology & therapeutics.

HIV RESISTANCE TO ANTIRETROVIRAL DRUGS: MECHANISMS, GENOTYPIC AND PHENOTYPIC RESISTANCE TESTING IN CLINICAL PRACTICE

M. Moutschen, P. Clevenbergh, D. Vaira, 2002, Acta clinica Belgica.

Hepatitis C of genotype 2: the role of medical invasive exams.

J. Belaiche, B. Rentier, D. Vaira, 2011, Acta gastro-enterologica Belgica.

Peroral infection of suckling mice with milk-borne mouse mammary tumour virus: uptake of the main viral antigens by the gut.

P. Hainaut, C. Calberg‐Bacq, D. Vaira, 1983, The Journal of general virology.

Natural infection of swiss mice with Mouse Mammary Tumor Virus (MMTV): Viral expression in milk and transmission of infection

P. Hainaut, C. Calberg‐Bacq, D. Vaira, 2005, Archives of Virology.

Anti M-protein antibody response to type A or B natural influenza detected by solid phase enzyme linked immunosorbent assay and by complement fixation

D. Vaira, L. Joassin, M. Reginster, 2005, Archives of Virology.

Synergistic Activation of HIV-1 Expression by Deacetylase Inhibitors and Prostratin: Implications for Treatment of Latent Infection

Arsène Burny, Dolores Vaira, J. Gatot, 2009, PloS one.

The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders.

C. Gennari, D. Vaira, N. Figura, 1999, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Implementation of a Classic Nested PCR DNA for HIVDiagnosis in Kinshasa

D. Vaira, G. M. Lelo, S. Mbikayi, 2014 .

DNA probe hybridisation in microwells using a new bioluminescent system for the detection of PCR-amplified HIV-1 proviral DNA.

J. Piette, J. Remacle, P. Moris, 1995, Journal of virological methods.

Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006.

Anne-Mieke Vandamme, Katrien Fransen, Inge Derdelinckx, 2008, AIDS research and human retroviruses.

Molecular testing of multiple HIV-1 transmissions in a criminal case

P. Lemey, F. Brun-Vézinet, A. Vandamme, 2005, AIDS (London).

HCV genotype 4 in Belgium: three distinct patterns among patients from European and African origin

D. Vaira, B. Bastens, C. Reenaers, 2006, European journal of gastroenterology & hepatology.

Combination of Serological Markers to Predict the Presence or Absence of Viremia in HCV‐Seropositive Blood Donors

D. Vaira, D. Sondag, H. Troonen, 1996, Vox sanguinis.

Correlation between Sequencing Results from Liquid Plasma and Dried Plasma Spot (DPS) for Determination of HIV Type 1 Non-B Subtypes

P. Mol, M. Hayette, D. Vaira, 2017 .

Prevalence of hepatitis G virus in a haemodialysis unit.

B. Rentier, G. Rorive, D. Vaira, 1999, Acta gastro-enterologica Belgica.

HIV-1 promoter activation following an oxidative stress mediated by singlet oxygen.

J. Piette, S. Legrand-Poels, B. Rentier, 1993, Journal of photochemistry and photobiology. B, Biology.

Comparison of an In-House Quantitative Real-Time PCR and COBAS AmpliPrep/TaqMan Roche for Determination of Viral Load for HIV Type 1 Non-B

P. Mol, M. Hayette, D. Vaira, 2015 .

Factors associated with late presentation for HIV care in a single Belgian reference center: 2006–2017

M. Moutschen, D. Vaira, G. Darcis, 2018, Scientific Reports.

Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pylori in dyspeptic patients.

L. Barbara, G. Biasco, J. Holton, 1993, Journal of clinical pathology.

The clinical role of cytochrome p450 genotypes in Helicobacter pylori management

F. Perna, G. Cantelli-forti, M. Miglioli, 2003, American Journal of Gastroenterology.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Exploring the link between innate immune activation and thymic function by measuring sCD14 and TRECs in HIV patients living in Belgium

M. Moutschen, V. Geenen, D. Vaira, 2017, PloS one.

Endoscopic therapy for bile duct stones in a geriatric population.

S. Williams, M. Charlton, D. Vaira, 1992, Postgraduate medical journal.

Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial

F. Perna, L. Gatta, J. Osborn, 2005, Gut.

Impact of coronavirus pandemic and containment measures on HIV diagnosis

M. Moutschen, D. Vaira, G. Darcis, 2020, Epidemiology and Infection.

The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence

J. Reggers, P. Gorwood, M. Ansseau, 2007, European Psychiatry.

Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group.

P. Malfertheiner, F. Mégraud, C. O'Morain, 1999, Lancet.

Impact of the COVID-19 pandemic situation on HIV care in Liège, Belgium

M. Moutschen, D. Vaira, G. Darcis, 2021, HIV research & clinical practice.

Horizontal gene transfer from human host to HIV-1 reverse transcriptase confers drug resistance and partly compensates for replication de fi cits

Guangdi Li, A. Vandamme, F. Rousseau, 2014 .

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

E. De Clercq, M. Van Ranst, C. Declercq, 2001, Antiviral therapy.

Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5‐year study on a large number of strains

C. Scarpignato, L. Gatta, J. Belsey, 2018, Alimentary pharmacology & therapeutics.

Diagnosis by PCR of HIV-1 infection in seronegative individuals at risk.

B. Rentier, C. François-Gérard, D. Vaira, 1990, AIDS research and human retroviruses.

Absence of Seroconversion in a PCR‐Positive Person 18 Months after Transfusion of HIV‐Infected Blood

B. Rentier, D. Vaira, D. Sondag‐Thull, 1989, Vox Sanguinis.

Food allergy and Helicobacter pylori infection.

P. Rottoli, C. Gennari, D. Vaira, 1999, Italian journal of gastroenterology and hepatology.

Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N’Djamena, Chad: findings from a cross-sectional study

M. Moutschen, A. Moussa, C. Adawaye, 2017, BMC Research Notes.

Resistance testing in children changing human immunodeficiency virus type 1 protease inhibitor

V. Arendt, J. Schmit, K. Fransen, 2002, The Pediatric infectious disease journal.

HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays

L. Stuyver, I. Vandenbroucke, M. Moutschen, 2010, AIDS research and therapy.

Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates

G. Nardone, R. Salerno, M. Romano, 2008, Journal of Clinical Pathology.

Diagnosis of Helicobacter pylori infection: which is the best test? The stool test.

F. Perna, M. Miglioli, L. Gatta, 2000, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Does HCV Screening of Blood Donors Affect Transmission of Hepatitis G Virus in Dialysed Patients?

B. Rentier, G. Rorive, D. Vaira, 1998, Vox Sanguinis.

Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.

M. Van Ranst, A. Vandamme, G. Zissis, 2003, FEMS immunology and medical microbiology.

The RIAD peptidomimetic inhibits HIV‐1 replication in humanized NSG mice

K. Taskén, S. Rahmouni, M. Moutschen, 2014, European journal of clinical investigation.

Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.

A. Vandamme, G. Zissis, K. Van Laethem, 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Review article: diagnosis of Helicobacter pylori infection.

M. Miglioli, L. Gatta, D. Vaira, 2002, Alimentary pharmacology & therapeutics.

A rapid, low‐dose, 13C‐urea tablet for the detection of Helicobacter pylori infection before and after treatment

F. Perna, C. Ricci, N. Vakil, 2003, Alimentary pharmacology & therapeutics.

Eighteen month follow up of Helicobacter pylori positive children treated with amoxycillin and tinidazole.

J. Holton, C. Ainley, J. Osborn, 1992, Gut.

Accuracy of the stool antigen test in the diagnosis of Helicobacter pylori infection before treatment and in patients on omeprazole therapy

G. Manes, D. Vaira, C. Ricci, 2001, Alimentary pharmacology & therapeutics.

Accuracy of a new ultrafast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive dyspeptic patients

F. Perna, N. Vakil, J. Holton, 2009, Alimentary pharmacology & therapeutics.

Diagnostic accuracy of a new rapid urease test (Pronto Dry), before and after treatment of Helicobacter pylori infection.

F. Perna, M. Miglioli, L. Gatta, 2005, Minerva gastroenterologica e dietologica.

Blood tests in the management of Helicobacter pylori infection

J. Holton, M. Miglioli, L. Gatta, 1998, Gut.

Prospective Screening of Dyspeptic Patients by Helicobacter pylori Serology: A Safe Policy?

D. Palli, R. Corinaldesi, V. Stanghellini, 1997, Endoscopy.

Diagnosis of Helicobacter pylori infection

C. Ricci, M. Miglioli, L. Gatta, 2002, Alimentary pharmacology & therapeutics.

Non-invasive techniques for the diagnosis of Helicobacter pylori infection.

L. Gatta, D. Vaira, C. Ricci, 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication courses

C. Hassan, A. Zullo, S. Morini, 2005, Alimentary pharmacology & therapeutics.

High eradication rates of Helicobacter pylori with a new sequential treatment

C. Hassan, A. Zullo, S. Morini, 2003, Alimentary pharmacology & therapeutics.

Twice-Daily Standard Dose of Omeprazole Achieves the Necessary Level of Acid Inhibition for Helicobacter pylori Eradication. A Randomized Controlled Trial Using Standard and Double Doses of Omeprazole in Triple Therapy

F. Perri, G. Nardone, G. Manes, 2005, Digestive Diseases and Sciences.

European multicentre validation trial of two new non‐invasive tests for the detection of Helicobacter pylori antibodies: urine‐based ELISA and rapid urine test

P. Malfertheiner, F. Mégraud, F. Bazzoli, 2003, Alimentary pharmacology & therapeutics.

Helicobacter pylori and diminished growth in children: is it simply a marker of deprivation?

J. Holton, M. Miglioli, D. Vaira, 1998, Italian journal of gastroenterology and hepatology.

Involvement of the Genetic Diversity of HIV-1 in the Virological Treatment Failure of First Line Antiretroviral in Kinshasa

M. Hayette, D. Vaira, E. Kamangu, 2017 .

Invasive and non‐invasive tests for Helicobacter pylori infection

C. Ricci, J. Holton, M. Miglioli, 2000, Alimentary pharmacology & therapeutics.

High rate of Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study

C. Hassan, A. Zullo, S. Morini, 2005, Alimentary pharmacology & therapeutics.